Lintopdrachten overslaan
Verdergaan naar hoofdinhoud
Omhoog

Hoe kunnen wij u helpen?

BEHANDELAAR

A - Z AZ lijst gebruiken om een pagina te vinden
Home > Behandelaars > Faber, J.

J. Faber

research coördinator

​Werkervaring:

  • 2015-heden: Research Coördinator Gynaecologie, Verloskunde en Voortplantingsgeneeskunde en Kindergeneeskunde Deventer Ziekenhuis
  • 2013-2015: Project Coördinator Immunologie/Oncologie bij Nutricia Advanced Medical Nutrition, Nutricia Research Utrecht
  • 2010-2013: Onderzoeker Immunologie/Oncologie bij Nutricia Advanced Medical Nutrition, Danone Research - Centre for Specialized Nutrition Wageningen
  • 2002-2010: Senior assistent onderzoeker bij Danone Research - Centre for Specialized Nutrition, Numico Research Wageningen

     
Opleidingen:

  • 2007-2011: PhD student aan Utrecht Institute for Pharmaceutical Sciences (Utrecht Universiteit) in samenwerking met Nutricia Advanced Medical Nutrition
    1998-2002: Biologie en Medisch Laboratoriumonderzoek aan Saxion Hogeschool in Enschede
  • 1992-1998: VWO aan Twickel college in Hengelo

Promoties:

  • 2012: Proefschrift: Immunological perspectives on nutritional support during cancer.

Publications:

  • Faber J, Uitdehaag MJ, Spaander MCW, van Steenbergen SCL, Vos AP, Berkhout M, Lamers CHJ, Rümke HC, Tilanus HW, Siersema PD, van Helvoort A, and van der Gaast A. Improved body weight and performance status and reduced serum PGE2 levels after nutritional intervention with a specific medical food in newly diagnosed patients with esophageal cancer or adenocarcinoma of the gastro-esophageal junction. J Cachexia Sarcopenia Muscle. 2015 March;6(1)32-44.
  • Abdi J, Garssen J, Faber J, Redegeld FA. Omega-3 fatty acids, EPA and DHA induce apoptosis and enhance drug sensitivity in multiple myeloma cells but not in normal peripheral mononuclear cells. J Nutr Biochem. 2014 Dec;25(12):1254-62.
  • Dwarkasing JT, van Dijk M, Dijk FJ, Boekschoten MV, Faber J, Argiles JM, Laviano A, Müller M, Witkamp RF, van Norren K. Hypothalamic food intake regulation in a cancer-cachectic mouse model. J Cachexia Sarcopenia Muscle. 2014 Jun;5(2):159-69.
  • Faber J, Berkhout M, Fiedler U, Avlar M, Witteman BJ, Vos AP, Henke M, Garssen J, van Helvoort A, Otten MH, Arends J. Rapid incorporation of EPA and DHA into white blood cells and reduced serum PGE2 levels after one week of nutritional intervention with a medical food in cancer patients receiving radiotherapy. Clin Nutr. 2013 Jun;32(3):338-45.
  • Faber J, van Limpt K, Kegler D, Luiking Y, Garssen J, van Helvoort A, Vos AP, Knol J. Bacterial translocation is reduced by a specific nutritional combination in mice with chemotherapy-induced neutropenia. J Nutr. 2011 Jul;141(7):1292-8.
  • Faber J, Berkhout M, Vos AP, Sijben JW, Calder PC, Garssen J, van Helvoort A. Supplementation with a fish oil-enriched, high-protein medical food leads to rapid incorporation of EPA into white blood cells and modulates immune responses within one week in healthy men and women. J Nutr. 2011 May;141(5):964-70.
  • Faber J, Vos AP, Kegler D, Argiles J, Laviano A, Garssen J, Van Helvoort A. Impaired immune function: An early marker for cancer cachexia. Oncol Rep. 2009;22:1403-6.
  • van Norren K, Kegler D, Argiles JM, Luiking Y, Gorselink M, Laviano A, Arts K, Faber J, Jansen H, et al. Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice. Br J Cancer. 2009;100:713-22.
  • van Hoffen E, Ruiter B, Faber J, M'Rabet L, Knol EF, Stahl B, Arslanoglu S, Moro G, Boehm G, Garssen J. A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. Allergy. 2009;64:484-7.
  • Faber J, Vos P, Kegler D, van Norren K, Argiles JM, Laviano A, Garssen J, van Helvoort A. Beneficial immune modulatory effects of a specific nutritional combination in a murine model for cancer cachexia. Br J Cancer. 2008;99:2029-36.
  • Hartog A, Hougee S, Faber J, Sanders A, Zuurman C, Smit HF, van der Kraan PM, Hoijer MA, Garssen J. The multicomponent phytopharmaceutical SKI306X inhibits in vitro cartilage degradation and the production of inflammatory mediators. Phytomedicine. 2008;15:313-20.
  • Hougee S, Faber J, Sanders A, Berg WB, Garssen J, Smit HF, Hoijer MA. Selective inhibition of COX-2 by a standardized CO2 extract of Humulus lupulus in vitro and its activity in a mouse model of zymosan-induced arthritis. Planta Med. 2006;72:228-33.
  • Hougee S, Faber J, Sanders A, de Jong RB, van den Berg WB, Garssen J, Hoijer MA, Smit HF. Selective COX-2 inhibition by a Pterocarpus marsupium extract characterized by pterostilbene, and its activity in healthy human volunteers. Planta Med. 2005;71:387-92.
  • Hougee S, Sanders A, Faber J, Graus YM, van den Berg WB, Garssen J, Smit HF, Hoijer MA. Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages. Biochem Pharmacol. 2005;69:241-8.

Context menu